1. Home
  2. MRVI vs TG Comparison

MRVI vs TG Comparison

Compare MRVI & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • TG
  • Stock Information
  • Founded
  • MRVI 2014
  • TG 1988
  • Country
  • MRVI United States
  • TG United States
  • Employees
  • MRVI 560
  • TG N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • MRVI Health Care
  • TG Industrials
  • Exchange
  • MRVI Nasdaq
  • TG Nasdaq
  • Market Cap
  • MRVI 350.1M
  • TG 301.0M
  • IPO Year
  • MRVI 2020
  • TG 1989
  • Fundamental
  • Price
  • MRVI $2.42
  • TG $7.84
  • Analyst Decision
  • MRVI Hold
  • TG
  • Analyst Count
  • MRVI 10
  • TG 0
  • Target Price
  • MRVI $5.84
  • TG N/A
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • TG 89.4K
  • Earning Date
  • MRVI 08-11-2025
  • TG 08-08-2025
  • Dividend Yield
  • MRVI N/A
  • TG N/A
  • EPS Growth
  • MRVI N/A
  • TG N/A
  • EPS
  • MRVI N/A
  • TG N/A
  • Revenue
  • MRVI $219,830,000.00
  • TG $643,014,000.00
  • Revenue This Year
  • MRVI N/A
  • TG N/A
  • Revenue Next Year
  • MRVI $7.23
  • TG N/A
  • P/E Ratio
  • MRVI N/A
  • TG N/A
  • Revenue Growth
  • MRVI N/A
  • TG 28.10
  • 52 Week Low
  • MRVI $1.67
  • TG $5.86
  • 52 Week High
  • MRVI $9.60
  • TG $9.43
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • TG 46.37
  • Support Level
  • MRVI $2.28
  • TG $7.68
  • Resistance Level
  • MRVI $2.47
  • TG $8.03
  • Average True Range (ATR)
  • MRVI 0.14
  • TG 0.20
  • MACD
  • MRVI -0.01
  • TG 0.06
  • Stochastic Oscillator
  • MRVI 27.45
  • TG 75.00

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: